A Single-Group Study to Evaluate the Effects of an Eyelash Serum on Improving Eyelash Growth

Sponsor
Dime Beauty Co. (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT06125730
Collaborator
Citruslabs (Industry)
35
1
1
3.3
10.8

Study Details

Study Description

Brief Summary

This study will evaluate the efficacy of the DIME Beauty Eyelash Boost Serum in improving the growth of the eyelashes and their appearance in terms of length, fullness, and thickness. This study will last for 60 days. The study will be conducted as a single-arm trial in which all participants will use the test product. Participants will be required to undertake questionnaires at Baseline, Day 30, and Day 60, photos will be taken at Baseline, Day 30, and Day 60, and expert eyelash grading will take place at Baseline and Day 60.

Condition or Disease Intervention/Treatment Phase
  • Other: DIME Beauty Eyelash Boost Serum
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Single-Group Study to Evaluate the Effects of an Eyelash Serum on Improving Eyelash Growth
Actual Study Start Date :
Aug 23, 2023
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: DIME Beauty Eyelash Boost Serum

Participants will use the eyelash serum twice daily in the morning and evening. The serum will be applied to the base of the top and bottom lashes.

Other: DIME Beauty Eyelash Boost Serum
The test product contains Water, Glycerin, Amino Acids (Sodium PCA, Sodium Lactate, Arginine, Aspartic Acid, PCA, Glycine, Alanine, Serine, Valine, Proline, Threonine, Isoleucine, Histidine, Phenylalanine), Hyaluronic Acid, Panthenol, Aloe Leaf Extract, Niacinamide, Purslane, Chebulic Fruit Extract, Apple Fruit Extract, Tocopherol, Phenoxyethanol, Hexanediol, Ethylhexylglycerin, Biotinoyl Tripeptide-1, Myristoyl Pentapeptide-4.

Outcome Measures

Primary Outcome Measures

  1. Changes in eyelash growth as per expert grading. [Timeframe: Baseline to Day 60] [60 days]

    Before & after photos of the eyelashes will undergo grading by an eyelash expert.

  2. Changes in participant-perceived eyelash growth. [Timeframe: Baseline to Day 60] [60 days]

    Measured via study-specific surveys. Surveys will be adapted from the validated Eyelash Satisfaction Questionnaire and designed on a 5-point Likert scale, with 5 representing the most favorable/best outcome (e.g., "Excellent") and 1 representing the least favorable/worst outcome (e.g., "Very poor").

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Females aged 18-65. Wish to improve their eyelash growth. Wish to improve their eyelash length, thickness, and fullness. Have a smartphone or camera to take before-and-after selfies.

Exclusion Criteria:

Anyone not in good health. Anyone who has any chronic health conditions such as oncological or psychiatric disorders.

Anyone who has undergone any procedures that target the eyelashes in the past 3 months, or is planning to in the next 60 days. This includes eyelash lifts, tints, and extensions.

Anyone who has recently started using any product or taking any supplements that target eyelash growth, or who is planning to in the next 60 days.

Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.

Anyone who is pregnant, breastfeeding, or wanting to become pregnant over the next three months.

Anyone who cannot/will not commit to the study protocol. Anyone with a history of substance abuse.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Citruslabs Santa Monica California United States 90404

Sponsors and Collaborators

  • Dime Beauty Co.
  • Citruslabs

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dime Beauty Co.
ClinicalTrials.gov Identifier:
NCT06125730
Other Study ID Numbers:
  • 20362
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 9, 2023